Trade BioNTech BNTX

BioNTech live chart

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

News

Webhose 2026 May 05, 21:17

Health Care Up After Earnings - Health Care Roundup | Morningstar

BioNTech SE
Webhose 2026 May 05, 14:14

BioNTech Q1 Earnings Call Highlights

BioNTech SE
Webhose 2026 May 05, 14:04

BioNTech (NASDAQ:BNTX) Announces Earnings Results - Zolmax

BioNTech SE
Webhose 2026 May 05, 12:58

BioNTech to cut up to 1,860 jobs as Covid jab sales drop

BioNTech SE
Webhose 2026 May 05, 07:04

BioNTech (NASDAQ:BNTX) Posts Earnings Results, Beats Estimates By $0.26 EPS - Daily Political

BioNTech SE
Webhose 2026 May 04, 03:17

BioNTech (BNTX) Is Down 7.5% After Tariff Jitters, Leadership Shifts And Cut Guidance Reset - Has The Bull Case Changed?

BioNTech SE
Webhose 2026 May 02, 10:31

BioNTech Faces Tariff Risks And Leadership Shift As Oncology Plans Advance

BioNTech SE
Webhose 2026 May 01, 17:53

BioNTech (NASDAQ:BNTX) Shares Gap Down - What's Next?

BioNTech SE
Webhose 2026 Apr 28, 12:00

CureVac targets Moderna with 10-patent suit over Spikevax

BioNTech SE
Webhose 2026 Apr 28, 11:39

BioNTech (BNTX) Expected to Announce Quarterly Earnings on Tuesday

BioNTech SE
Webhose 2026 Apr 28, 11:34

BioNTech SE Sponsored ADR $BNTX Shares Sold by Flossbach Von Storch SE

BioNTech SE
Webhose 2026 Apr 28, 08:20

BioNTech (BNTX) - Research Analysts' Recent Ratings Updates - Daily Political

BioNTech SE
Webhose 2026 Apr 28, 00:00

BioNTech Stock Forecast | Co-Founder Exit, 2026 Guidance Cut | Capital.com

BioNTech SE
Webhose 2026 Apr 27, 12:21

HC Wainwright Reaffirms "Buy" Rating for BioNTech (NASDAQ:BNTX)

BioNTech SE
Webhose 2026 Apr 27, 12:01

BNTX Reiterates by HC Wainwright & Co. -- Price Target Maintaine

BioNTech SE
Webhose 2026 Apr 24, 20:55

CureVac sues Moderna for patent infringement over COVID-19 vaccines

BioNTech SE
Webhose 2026 Apr 24, 13:43

BioNTech SE (BNTX) PT Slightly Raised as Morgan Stanley Updates Biopharma Coverage Models

BioNTech SE
Webhose 2026 Apr 23, 21:57

Sierk Poetting Sells 50,000 Shares of BioNTech (NASDAQ:BNTX) Stock

BioNTech SE
Webhose 2026 Apr 23, 20:06

Why BioNTech (BNTX) Is Up 9.2% After Strong Phase 2 HER2 ADC Data In Endometrial Cancer

BioNTech SE
Webhose 2026 Apr 23, 16:45

BioNTech (BNTX) Price Target Raised Following Successful T-Pam Data

BioNTech SE
Webhose 2026 Apr 23, 14:56

BioNTech (NASDAQ:BNTX) COO Sierk Poetting Sells 50,000 Shares - Daily Political

BioNTech SE
Webhose 2026 Apr 22, 11:22

BioNTech (BNTX) Is Up 13.4% After Positive HER2 Endometrial Cancer Phase 2 Data Release

BioNTech SE
Webhose 2026 Apr 21, 20:03

BNTX: Leadership Turnover And Weak COVID Outlook Will Pressure Future Expectations

BioNTech SE
Webhose 2026 Apr 21, 18:28

BioNTech (BNTX) Gains Investor Interest Following Promising ASCO Presentation

BioNTech SE
Webhose 2026 Apr 20, 14:05

Assessing BioNTech (NasdaqGS:BNTX) Valuation After Recent Share Price Momentum

BioNTech SE
Webhose 2026 Apr 16, 12:07

BioNTech And Boehringer Trial Adds Dimension To Small Cell Lung Cancer Story

BioNTech SE
Webhose 2026 Apr 16, 10:28

Lbp Am Sa Acquires 15,255 Shares of BioNTech SE Sponsored ADR $BNTX

BioNTech SE
Webhose 2026 Apr 15, 23:20

BioNTech's (BNTX) Buy Rating Reiterated at Berenberg Bank - Daily Political

BioNTech SE
Webhose 2026 Apr 15, 03:11

BioNTech (BNTX) Is Up 9.8% After Strong Phase 2 HER2 ADC Data - Has The Bull Case Changed?

BioNTech SE
Webhose 2026 Apr 14, 03:20

Analysts Set BioNTech SE Sponsored ADR (NASDAQ:BNTX) Target Price at $133.13 - Stock Observer

BioNTech SE
Webhose 2026 Apr 13, 09:52

BioNTech (NASDAQ:BNTX) Earns "Buy" Rating from Berenberg Bank - Stock Observer

BioNTech SE
Webhose 2026 Apr 12, 19:24

A Look At BioNTech (BNTX) Valuation After Positive Phase 2 HER2 Endometrial Cancer Data

BioNTech SE
Webhose 2026 Apr 12, 16:20

BioNTech announce Phase 2 cohort of BNT323 met primary efficacy endpoint | Markets Insider

BioNTech SE
Webhose 2026 Apr 11, 11:00

BioNTech and DualityBio's Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Meaningful Efficacy in Patients with HER2-Expressing, Recurrent Endometrial Cancer | Taiwan News | Apr. 11, 2026 19:00

BioNTech SE
Webhose 2026 Apr 11, 06:31

BioNTech SE Sponsored ADR (NASDAQ:BNTX) Given Consensus Recommendation of "Moderate Buy" by Analysts

BioNTech SE
Webhose 2026 Apr 10, 14:32

BioNTech (NASDAQ:BNTX) Stock Price Expected to Rise, Morgan Stanley Analyst Says

BioNTech SE
Webhose 2026 Apr 09, 07:02

Aberdeen Group plc Lowers Stock Position in BioNTech SE Sponsored ADR $BNTX

BioNTech SE
Webhose 2026 Apr 08, 20:04

How The BioNTech (BNTX) Story Is Shifting With New Leadership And Post COVID Pipeline Bets

BioNTech SE
Webhose 2026 Apr 07, 18:16

Is BioNTech (BNTX) Quietly Rewriting Its Investment Story Around Oncology Beyond COVID Vaccines?

BioNTech SE

BioNTech News

number1 2025 Dec 05, 00:01

Pimco's Triumph in 2025: A Bold Bond Strategy Pays Off

number1 2025 Dec 04, 00:00

Fed Independence on the Line? Political Influence in 2026

number1 2025 Dec 04, 00:00

US Holiday Shopping Season: Record Online Sales Amid Economic Vulnerabilities

number1 2025 Dec 03, 00:00

US Economic Outlook 2026: A Roubini Analysis

number1 2025 Dec 02, 00:01

Fed's Divergent Votes: A Sign of Policy Uncertainty?

Frances Wang 2024 Dec 29, 16:00

Trading wisdom: how can I improve myself as a trader?

Frances Wang 2024 Dec 26, 16:00

Can you trade CFDs on crypto: platform to trade cryptocurrency CFDs

Frances Wang 2024 Dec 25, 16:00

EQV stock price today: Is EQV Ventures a good investment?

Frances Wang 2024 Dec 25, 16:00

How to start investing in dividend ETFs: 7 Dividend ETFs to Watch

Frances Wang 2024 Dec 23, 16:00

TSLQ ETF price forecast: How to track TSLQ ETF prices?

Latest news

Show more
number1 2026 Mar 14, 00:00

Russia Reportedly Providing Intelligence Support to Iran Amidst Escalating Middle East Conflict

number1 2026 Mar 14, 00:00

US Economic Signals: Inflation Concerns and Growth Challenges

number1 2026 Mar 14, 00:00

Gold Market Analysis: Navigating Stability Amidst Escalating Geopolitical Tensions

number1 2026 Mar 14, 00:00

Apple Slashes App Store Commissions in China for Developers

number1 2026 Mar 14, 00:00

Geopolitical Tensions, Economic Crosscurrents, and Technological Advancements: A Forward-Looking Analysis

number1 2026 Mar 13, 12:07

Aussie Dollar Sees Surge in Bullish Bets Ahead of Reserve Bank of Australia Rate Decision

number1 2025 Dec 06, 00:00

India's Silver Demand Surge: New Loan Framework Boosts Market

number1 2025 Dec 04, 00:00

ADP Employment Data and the Fed's Policy Path: A Closer Look

Info

Spread

1.3177

Spread (%)

1.4541 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Tuesday

13:31 - 19:59

Monday

13:31-19:59

Wednesday

13:31-19:59

Thursday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

24150446080

Shares Outstanding

252884261

Earnings Date (Next)

0000-00-00

Div Yield

2022-06-17

Ex-Dividend Date

2022-06-02

Forward annual dividend rate

0

Forward annual dividend yield

0

EPS

-5.95

Learn more about this instrument

BioNTech BioNTech SE
BioNTech SE, together with its subsidiaries, engages in the development and commercialization of immunotherapies in Germany. The company offers BNT162, an mRNA vaccine for the treatment of SARS-CoV-2 virus. It also develops oncology drugs under Phase III clinical trial, including Gotistobart for metastatic non-small cell lung cancer, Pumitamig for small cell lung cancer and advanced/metastatic triple-negative breast cancer, and Trastuzumab pamirtecan for metastatic breast cancer and epirubicin and cyclophosphamide; and drugs under Phase 2/3 clinical trial, such as BNT113 for human papillomavirus and head and neck squamous cell carcinoma, as well as Pumitamig for metastatic colorectal and non-small cell lung cancer. In addition, the company engages in the development of oncology drugs under Phase II clinical trial comprising BNT116 for advance non-small cell lung cancer, BNT326/YL202 for multiple solid tumors and advanced/metastatic breast cancer, Autogene cevumeran for advance colorectal cancer, and Gotistobart for platinum-resistant ovarian cancer, as well as Pumitamig for glioblastoma, hepatocellular carcinoma, malignant pleural mesothelioma, neuroendocrine neoplasms, and metastatic pancreatic ductal adenocarcinoma. Further, it develops BNT166 which is Phase II clinical trial for mpox virus; and infectious diseases drugs under Phase 1/2 clinical trial, which include BNT162 + BNT161 for SARS-CoV-2 and influenza, BNT164 for tuberculosis, BNT165 for malaria, and BNT166 for mpox. The company was incorporated in 2008 and is headquartered in Mainz, Germany.

Related Instruments

Asset
Sell
Buy
Change (%)
View all instruments

Latest Education Articles

Show more
Trustpilot